EXAS
Exact Sciences Corporation Healthcare - Diagnostics Investor Relations →
Exact Sciences Corporation (EXAS) closed at $104.91 as of 2026-03-20, trading 68.4% above its 200-week moving average of $62.29. The stock moved further from the line this week, up from 67.0% last week. With a 14-week RSI of 89, EXAS is in overbought territory.
A big jump in activity this week — 3.5x the usual volume, and the price went up. Significantly more people than usual decided to buy. This kind of surge, especially on a stock already below its 200-week average, can be an early sign that sentiment is shifting.
Over the past 1263 weeks of data, EXAS has crossed below its 200-week moving average 11 times. On average, these episodes lasted 51 weeks. Historically, investors who bought EXAS at the start of these episodes saw an average one-year return of +21.1%.
With a market cap of $20.0 billion, EXAS is a large-cap stock. The company generates a free cash flow yield of 1.4%. Return on equity stands at -8.7%. The stock trades at 8.3x book value.
Share count has increased 7.2% over three years, indicating dilution.
Over the past 24.2 years, a hypothetical investment of $100 in EXAS would have grown to $1072, compared to $891 for the S&P 500. That represents an annualized return of 10.3% vs 9.4% for the index — confirming EXAS as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: EXAS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After EXAS Crosses Below the Line?
Across 11 historical episodes, buying EXAS when it crossed below its 200-week moving average produced an average return of +22.9% after 12 months (median -12.0%), compared to +6.9% for the S&P 500 over the same periods. 27% of those episodes were profitable after one year. After 24 months, the average return was +77.1% vs +23.7% for the index.
Each line shows $100 invested at the moment EXAS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
EXAS has crossed below its 200-week MA 11 times with an average 1-year return of +21.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Feb 2002 | Mar 2002 | 5 | 17.5% | -12.5% | +1223.0% |
| Dec 2002 | Dec 2002 | 2 | 5.6% | -8.1% | +899.1% |
| Jan 2003 | May 2003 | 17 | 35.1% | -2.0% | +949.1% |
| Oct 2003 | Oct 2007 | 206 | 80.7% | -74.2% | +942.8% |
| Dec 2007 | Dec 2007 | 2 | 9.8% | -87.9% | +3079.1% |
| Jan 2008 | Jun 2009 | 76 | 85.0% | -68.1% | +3284.2% |
| Oct 2015 | Jul 2016 | 42 | 62.5% | +126.6% | +1132.8% |
| Nov 2016 | Jan 2017 | 8 | 14.5% | +305.7% | +623.0% |
| Mar 2020 | Apr 2020 | 4 | 10.6% | +132.6% | +90.0% |
| Nov 2021 | Jun 2023 | 81 | 66.6% | -49.4% | +24.8% |
| Aug 2023 | Oct 2025 | 114 | 47.5% | -30.8% | +27.4% |
| Average | 51 | — | +21.1% | — |
Frequently Asked Questions
Is EXAS below its 200-week moving average?
No. Exact Sciences Corporation (EXAS) is currently 68.4% above its 200-week moving average of $62.29. It would need to fall to $62.29 to cross below the line.
What is EXAS's 200-week moving average price?
Exact Sciences Corporation's 200-week moving average is $62.29 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when EXAS drops below its 200-week moving average?
EXAS has crossed below its 200-week moving average 11 times in our data. On average, buying at that moment produced a one-year return of +21.1%. These dips have historically been decent entry points. These episodes lasted 51 weeks on average.
Is EXAS a good value right now?
Here's what our data says about EXAS as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 89 (overbought). Free cash flow yield is 1.4%. Return on equity is -8.7%. Price-to-book is 8.3x. This is not a buy or sell recommendation — always do your own research.
How does EXAS compare to the S&P 500?
Over the past 24.2 years, $100 invested in EXAS would have grown to $1072, compared to $891 for the S&P 500. That's 10.3% annualized vs 9.4% for the index. EXAS has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20